The current valuation score of Minerva Neurosciences Inc is 8.65, ranking 76 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.11, which is -13214.23% below the recent high of 14.10 and -5552.47% above the recent low of -6.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.